TIBET AIM PHARM. INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.91 CNY | +0.34% |
|
+16.93% | -24.94% |
| Apr. 26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
TIBET AIM PHARM INC is a China-based company principally engaged in the research, design, manufacture and distribution of chemical drugs and Chinese patent medicine. The Companyâs products include self-manufacturing medicine and third-party medicine. Self-manufacturing medicine includes miglitol tablets, hongjinxiaojie tablet, aceclofenac enteric-coated tablets, montmorillonite powder, as well as domperidone tablets, among others. Its third-party medicine includes gualoupi injection, nalmefene hydrochloride injection, oral liquid for children, cefotaxime sodium for injection, as well as carbetocin injection. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -24.94% | 235M | |
| +33.66% | 704B | |
| +28.59% | 577B | |
| -3.45% | 348B | |
| +18.90% | 327B | |
| +4.62% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.81% | 147B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million
